Potential benefit of extended dose schedules of human papillomavirus vaccination in the context of scarce resources and COVID-19 disruptions in low-income and middle-income countries: a mathematical modelling analysis

Élodie Bénard(Centre hospitalier de l'Université Laval), Marc Brisson(Centre hospitalier universitaire de Québec), Jean‐François Laprise(Université Laval), Kiesha Prem(National University of Singapore), Marie‐Claude Boily(Imperial College London), Mark Jit(London School of Hygiene & Tropical Medicine), Mélanie Drolet(Centre hospitalier de l'Université Laval)
The Lancet Global Health
December 13, 2022
Cited by 18


Related Papers